Author/Authors :
Faik ALTINTAS، نويسنده , , Hakan GURBUZ، نويسنده , , Bulent ERDEMLI، نويسنده , , Bulent ATILLA، نويسنده , , Recep Gur USTAOGLU، نويسنده , , Ugur OZIC، نويسنده , , Oner SAVK، نويسنده , , Huseyin BAYRAM، نويسنده , , Recep MEMIK، نويسنده , , Isik AKGUN، نويسنده , , Abdullah GOGUS، نويسنده , , Fatih PESTILCI، نويسنده , , Adnan KONAL، نويسنده , , Mahmut ARGUN، نويسنده , , Irfan Ozturk، نويسنده , , Nevzat DABAK، نويسنده , , Omer Faruk BILGEN، نويسنده , , Erhan Serin، نويسنده , , Cetin ONDER، نويسنده , , Aykin SIMSEK، نويسنده , , Remzi TOZUN، نويسنده , , Hakan KINIK ، نويسنده ,
Abstract :
Objectives: We investigated risk factors for venous throm¬boembolism (VTE), prophylaxis measures employed, and in¬cidence of symptomatic deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing major or¬thopaedic surgery (MOS). Methods: An open, multicenter, prospective, observational study was conducted in 21 medical centers, comprising 899 patients. Of these, 316 patients (35.2%) underwent total hip arthroplasty (THA), 328 patients (36.5%) underwent total knee arthroplasty (TKA), and 255 patients (28.4%) underwent surgery for hip fractures (HF). Pharmacologic prophylaxis was employed in all the patients. Results: Risk factors for VTE were seen in 73.2% of the pat¬ents, the most common being obesity (72%) and prolonged im¬mobilization (36.3%). Low-molecular-weight heparin (91.1%) and fondaparinux (8.9%) were used for prophylaxis, which was short-term in 273 patients (30.4%) and long-term in 626 patients (69.6%). Mechanical prophylaxis was performed with compres¬sion stockings in 610 patients (67.9%) and by intermittent pneu¬matic compression in 67 patients (7.5%). During three-months of follow-up, symptomatic DVT and PE were seen in eight (0.9%) and four patients (0.4%), respectively. Mortality occurred in 10 patients (1.1%). Complications of major and minor bleeding were seen in eight (0.9%) and 40 (4.5%) patients, respectively. Conclusion: Effective VTE prophylaxis is associated with low risk of clinically apparent DVT and PE in MOS.
Keywords :
Arthroplasty , replacement , Hip , replacement , KNEE , postoperative complications , thromboembolism , Venous Thrombosis , ANTICOAGULANTS , Therapeutic use , Arthroplasty , risk factors